Grown Rogue International (GRUSF) EPS (Weighted Average and Diluted) (2013 - 2026)
Grown Rogue International (GRUSF) recorded quarterly EPS (Weighted Average and Diluted) of $249.9 million in Q1 2026, up 2366783.93% quarter-over-quarter from $10558.8 in Q3 2025, and up 10402393451621.12% on a YoY basis from N/an in Q1 2025.
Grown Rogue International (GRUSF) EPS (Weighted Average and Diluted) (2013 - 2026) Analysis & Trends
Grown Rogue International's EPS (Weighted Average and Diluted) history runs 10 years deep, the most recent figure standing at $249.9 million for Q1 2026.
- In Q1 2026, EPS (Weighted Average and Diluted) rose 10402393451621.12% year-over-year to $249.9 million; the TTM figure through Mar 2026 stood at $249.9 million (up 62041177062.32% YoY), while the FY2025 annual figure was $0.01, down 100.0% from the prior year.
- EPS (Weighted Average and Diluted) was $249.9 million for Q1 2026 at Grown Rogue International, up from $10558.8 in the prior quarter.
- In the past five years, EPS (Weighted Average and Diluted) ranged from a high of $249.9 million in Q1 2026 to a low of -$0.03 in Q2 2024.
- Historically, EPS (Weighted Average and Diluted) has averaged $22.7 million across 4 years, with a median of $0.0 in 2023.
- The sharpest annual moves came in 2025 and 2026: EPS (Weighted Average and Diluted) jumped 112.25% in 2025, then jumped 10402393451621.12% in 2026.
- A 4-year view of EPS (Weighted Average and Diluted) shows it stood at $0.0 in 2023, then jumped by 1779157281.41% to $53431.2 in 2024, then slumped by 80.24% to $10558.8 in 2025, then soared by 2366783.93% to $249.9 million in 2026.
- The last three EPS (Weighted Average and Diluted) figures came in at $249.9 million (Q1 2026), $10558.8 (Q3 2025), and $0.01 (Q2 2025), per Business Quant data.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EPS (Weighted Avg. Diluted) (Qtr) |
|---|---|---|---|---|---|
| 1 | Teva Pharmaceutical Industries | 38.34 Bn | 34.60 Bn | 1.97 Bn | 0.31 |
| 2 | Zoetis | 33.27 Bn | 31.33 Bn | 1.62 Bn | 1.42 |
| 3 | United Therapeutics | 23.75 Bn | 21.60 Bn | 648.10 Mn | 5.82 |
| 4 | Aurora Cannabis | 17.11 Bn | 17.03 Bn | 33.43 Mn | 0.02 |
| 5 | Neurocrine Biosciences | 16.37 Bn | 15.05 Bn | 800.70 Mn | 1.91 |
| 6 | Elanco Animal Health | 11.78 Bn | 11.35 Bn | 785.00 Mn | 0.11 |
| 7 | Alkermes | 7.05 Bn | 6.54 Bn | -116.06 Mn | -0.40 |
| 8 | Lantheus Holdings | 6.49 Bn | 5.99 Bn | 230.92 Mn | 1.80 |
| 9 | Hims & Hers Health | 6.19 Bn | 5.44 Bn | 396.79 Mn | -0.40 |
| 10 | Grown Rogue International | - | - | 3.96 Mn | 249.91 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 249.91 Mn |
| Sep 30, 2025 | 10,558.80 |
| Jun 30, 2025 | 0.01 |
| Mar 31, 2025 | 0.00 |
| Dec 31, 2024 | 53,431.23 |
| Sep 30, 2024 | 0.00 |
| Jun 30, 2024 | -0.03 |
| Mar 31, 2024 | -0.02 |
| Dec 31, 2023 | 0.00 |
| Oct 31, 2023 | -0.01 |
| Jul 31, 2023 | 0.00 |
| Oct 31, 2021 | 0.00 |
| Aug 31, 2017 | -0.35 |
| May 31, 2017 | -0.06 |
| Feb 28, 2017 | 0.00 |
| Nov 30, 2016 | -0.02 |
| Aug 31, 2016 | -5.48 |
| May 31, 2016 | 0.02 |
| Feb 29, 2016 | 0.01 |
| Nov 30, 2015 | 0.14 |